Company Overview and News

Tunku Shazuddin appointed Naza Italia chairman

2018-04-17 themalaymailonline
KUALA LUMPUR, April 17 — Naza Corporation Holdings today announced the appointment of Datuk Tunku Shazuddin Ariff Ibni Sultan Sallehuddin as chairman of its subsidiary Naza Italia Sdn Bhd.

RHB Research positive on Berjaya Food

2018-03-16 themalaymailonline
At lunch break, Berjaya Food’s share price in Bursa Malaysia eased eight sen to RM1.75 with 241,800 shares traded. — Reuters picKUALA LUMPUR, March 16 — RHB Research is positive on food and beverages chain operator, Berjaya Food Bhd, on the back of sustainable growth driven by Starbucks through expansion of outlets and better consumer sentiment moving forward.

Berjaya Food hit by 4% stock drop after results

KUALA LUMPUR: Shares of Berjaya Food Bhd (BFood) fell 4% as the company's slipped into a net loss in the three months to January 31.

Trading ideas: WZ Satu, Berjaya Food, Pestech, Zecon

KUALA LUMPUR: JF Apex Research expects WZ Satu Bhd , Berjaya Food Bhd, Pestech International Bhd and Zecon Bhd to generate trading interest following their latest corporate news.

Luxury car dealership business drives Berjaya PHL’s Q3 profit

2018-03-14 bworldonline
BERJAYA Philippines, Inc. booked a single-digit growth in the quarter ending January 2018, as the company recorded higher sales in its luxury automobiles segment.

Berjaya PHL invests in Malaysian restaurant operator

2018-02-26 bworldonline
BERJAYA Philippines, Inc. said it has invested in a company that operates the Starbucks and Kenny Rogers Roasters brands in Malaysia.

Starbucks remains backbone of Berjaya Food

KUALA LUMPUR: CIMB Equities Research expects Starbucks to continue to be Berjaya Food ’s key growth driver and it expects it to stay on its positive earnings trajectory on the back of a healthy store expansion. The research house said on Monday BFood plans to add 25 to 30 new stores a year. Out of the 25-30 stores, approximately 10 will be allocated as drive-through outlets, which typically fetch higher margins vs.

Trading ideas: Supermax, Top Glove, Berjaya Food, Ann Joo

KUALA LUMPUR: Supermax Corp Bhd , Top Glove Corp Bhd , Berjaya Food Bhd and Ann Joo are among the stocks to watch on Monday, according to JF Apex Research.

Trading ideas: Berjaya Food, Kimlun, Hibiscus Petroleum

KUALA LUMPUR: JF Apex expects Berjaya Food , Kimlun, Hibiscus Petroleum and Berjaya Corp to be among the stocks to see trading interests on Monday.

Astro 'add', Top Glove 'hold', Bursa 'neutral'

ASTRO Malaysia Holdings Bhd’s revenue fell 2.7% year-on-year (y-o-y) in the first quarter of financial year 2018 (Q1FY18) due to lower TV subscription revenue, decline in TV and radio adex, and decrease in licensing income due to the expiry of its sports channel’s sub-licensing agreement.

CIMB Research downgrades Berjaya Food to reduce, lower target price

CIMB Research said although Berjaya Food’s 4QFY4/17 revenue grew 8.9% on-year to RM151.4mil, core net profit was down 49.3% on-year at RM1.6mil.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...